Showing results (151-160 of 2,229) with videos related to
Sort By:
Pageof 223
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Rhenium-188--a generator-derived radioisotope for cancer therapyF F KnappCancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Elevated plasma levels of interleukin-1 receptor antagonist are associated with decreased cellular BCL-2 oncoprotein expression in B-chronic lymphocytic leukemiaS Duensing, A Nasarek, J Grosse, et al.Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Lovastatin inhibits tumor growth and metastasis development of a rat fibrosarcomaP Matar, V R Rozados, E A Roggero, et al.Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Anti-tumor effect of methanol extracts from red and white winesH Kamei, Y Hashimoto, T Koide, et al.Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Evaluation in a mouse model of a thyroid-blocking protocol for 131I antibody therapy (short communication)L S Zuckier, Y Li, C J ChangCancer Biotherapy & Radiopharmaceuticals|February 1, 1997
Apoptosis of tumor cells induced by substances of the circulatory systemG KulcsárCancer Biotherapy & Radiopharmaceuticals|February 1, 1997
Patterns of hepatic and splenic colonization by an attenuated strain of Salmonella typhimurium containing the gene for human interleukin-2: a novel anti-tumor agentD A Saltzman, E Katsanis, C P Heise, et al.Cancer Biotherapy & Radiopharmaceuticals|February 1, 1997
Tumor cell growth suppression by chalcone (1,3-diphenyl-2-propen-1-one)H Kamei, T Koide, Y Hashimoto, et al.Cancer Biotherapy & Radiopharmaceuticals|April 1, 1997
Antitumor vaccination with gene-transduced tumor cells expressing a fusion protein RM4/IFN-tauJ XiangCancer Biotherapy & Radiopharmaceuticals|April 1, 1997
Inhibition of HeLa cell proliferation by 4-hydroxynonenal is associated with enhanced expression of the c-fos oncogeneT Kreuzer, N Zarković, R Grube, et al.Pageof 223